SecBot SecBot
DEFA14A ·Filed Apr 22, 2026

NSPR

InspireMD, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0001493152-26-018558
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for future share issuances or capital raises, as the increased share authorization facilitates potential equity financing. The clarification improves the likelihood of Proposal 2 passing due to broker voting discretion.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
NSPR ▼ -45.01% at T+60d
NEUTRAL call -45.01% · α vs SPY -50.03% · entry $1.28 → $0.7039
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
-2.34%
call -2.34% · α -3.13%
$1.25
settled 6mo ago
T+5d
-10.94%
call -10.94% · α -12.42%
$1.14
settled 6mo ago
T+20d
-21.88%
call -21.88% · α -26.51%
$1.00
settled 5mo ago
T+60d
-45.01%
call -45.01% · α -50.03%
$0.7039
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

InspireMD, Inc. issued a supplemental proxy statement clarifying that Proposal 2 — increasing the authorized number of common shares from 150 million to 250 million — is considered a 'routine' matter under NYSE rules, allowing brokers to vote uninstructed shares on this proposal. This update affects voting procedures for the June 3, 2026 annual meeting.

Key Financial Metrics

Meeting
2026-06-03

Key Facts

  • The filing is a DEFA14A supplement to the 2026 annual meeting proxy statement.
  • Proposal 2 seeks to increase authorized common stock from 150 million to 250 million shares.
  • The company clarified that this proposal is 'routine' under NYSE rules, enabling broker discretionary voting on uninstructed shares.
  • Meeting date is June 3, 2026; no opposition or activist involvement is indicated.

Financial Impact

Enables future equity financing flexibility; no immediate dilution as no offering is announced.

authorized_sharespotential_dilutionvoting_procedure

Risk Factors

  • Future dilution risk if additional shares are issued at low prices.
  • Governance concerns from significant share reserve increase without immediate disclosed use.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-018558
Document: 0001493152-26-018558-index-headers.html0001493152-26-018558
Document: 0001493152-26-018558-index.html0001493152-26-018558
Document: 0001493152-26-018558.txt0001493152-26-018558
19 reports for NSPR
Performance horizon
67% Hit rate @ T+5 6 of 9 directional calls Went positive at some point 8 of 9 best @ T+60▲ +54.19%Apr 3, 2026
Filters
Rows
Reports for NSPR — sortable, filterable
TypeNow
Sep 21, 2026
5w ago
8-K
MIXED ★ 5/10
$0.7500 $0.6895▼ −8.07%▼ −7.05%$0.4500 (−40.00%)
Sep 21, 2026
5w ago
Press Release
NEUTRAL ★ 5/10
$0.7500 $0.6895▼ −8.07%▼ −7.05%$0.4500 (−40.00%)
Aug 17, 2026
10w ago
8-K
BEARISH ★ 6/10
$0.8798 $0.8699▲ +1.13%▼ −0.07%$0.4500 (+48.85%)
Aug 17, 2026
10w ago
Press Release
BEARISH ★ 6/10
$0.8798 $0.8699▲ +1.13%▼ −0.07%$0.4500 (+48.85%)
Aug 10, 2026
11w ago
Press Release
NEUTRAL ★ 1/10
$0.8500 $0.8816▲ +3.72%▲ +4.12%$0.4500 (−47.06%)
Jul 29, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$0.6718 $0.7222▲ +7.50%▲ +3.88%$0.4500 (−33.02%)
Jul 23, 2026
13w ago
8-K
BEARISH ★ 7/10
$0.6835 $0.6718▲ +1.71%▲ +2.09%$0.4500 (+34.16%)
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$0.6990 $0.7121▲ +1.87%▲ +0.94%$0.4500 (−35.62%)
May 21, 2026
22w ago
Insider Cluster
NEUTRAL ★ 4/10
$1.00 $0.9900▼ −1.00%▼ −2.66%$0.4500 (−55.00%)
May 15, 2026
23w ago
Insider Cluster
BULLISH ★ 6/10
$1.05 $0.9500▼ −9.52%▼ −11.14%$0.4500 (−57.14%)
Showing 10 of 19

US Market Status

Market Closed — Opens in 1h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026